NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



CNS Tumors



High 123I-IMP is seen on SPECT image in primary CNS lymphoma



April 22nd, 2003

High 123I-IMP is seen on SPECT image in primary CNS lymphoma, but not in glioma or meningioma.

According to a study from Japan, "The purpose of this study is to characterize the time course of N-isopropyl-p-[123I]-iodoamphetamine (123I-IMP) uptake of primary central nervous system lymphomas (PCNSL) as compared with other common brain tumors such as malignant gliomas and meningioma.

"Ten patients with PCNSL, 14 with malignant gliomas and 7 with meningioma underwent 123I-IMP single photon emission computerized tomography (SPECT). Four (40%), 7 (70%) and 9 cases (90%) of PCNSL showed IMP index >1 on early...


Source: Cancer Weekly (2003-04-22)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login